Folgen
Roxane Rohani
Roxane Rohani
Assistant Professor of Pharmacology, Rosalind Franklin University of Medicine and Science
Bestätigte E-Mail-Adresse bei rosalindfranklin.edu
Titel
Zitiert von
Zitiert von
Jahr
Adherence to antiretroviral therapy among Iranian HIV/AIDS patients
H Khalili, R Rohani, S Seyedalinaghi, M Hajiabdolbaghi, ...
Current clinical pharmacology 7 (2), 111-115, 2012
432012
Machine learning to stratify methicillin-resistant staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia
NJ Rhodes, R Rohani, PR Yarnold, AE Pawlowski, M Malczynski, C Qi, ...
Antimicrobial agents and chemotherapy 67 (1), e01023-22, 2023
122023
Optimizing aminoglycoside dosing regimens for critically ill pediatric patients with augmented renal clearance: a convergence of parametric and nonparametric population approaches
SN Avedissian, R Rohani, J Bradley, J Le, NJ Rhodes
Antimicrobial Agents and Chemotherapy 65 (4), 10.1128/aac. 02629-20, 2021
92021
Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
GM Pais, S Marianski, K Valdez, RP Melicor, J Liu, R Rohani, J Chang, ...
British Journal of Pharmacology 181 (5), 670-680, 2024
42024
Defining the importance of age-related changes in drug clearance to optimizing aminoglycoside dosing regimens for adult patients with cystic fibrosis
R Rohani, B Hoff, M Jain, A Philbrick, S Salama, JF Cullina, NJ Rhodes
European Journal of Drug Metabolism and Pharmacokinetics, 1-11, 2022
32022
Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV
R Rohani, J Malakismail, E Njoku
Current HIV/AIDS Reports 20 (6), 394-404, 2023
22023
2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
R Rohani, PR Yarnold, MH Scheetz, MN Neely, M Kang, HK Donnelly, ...
Open Forum Infectious Diseases 10 (Suppl 2), 2023
22023
Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
R Rohani, PR Yarnold, MH Scheetz, MN Neely, M Kang, HK Donnelly, ...
Antimicrobial agents and chemotherapy 67 (12), e00727-23, 2023
12023
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
R Rohani, MH Scheetz, HK Donnelly, A Donayre, M Kang, E Diaz, ...
Journal of Antimicrobial Chemotherapy 77 (11), 2956-2959, 2022
12022
Expanding expedited partner therapy and HIV prophylaxis in the emergency department
KJ Mercer, MB Brizzi, DN Burhoe, JM Senn, R Rohani, DN Nowicki, ...
American Journal of Health-System Pharmacy 81 (8), 279-290, 2024
2024
Determination of Meropenem Stability in Simulated Bronchoalveolar Lavage Fluid (BALF) Samples
R Rohani, MH Scheetz, RG Wunderink, A Misharin, K Dedicatoria, ...
2021 ACCP VIRTUAL Annual Meeting, 2021
2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–11